Everything you need to know about TMS During Pregnancy and Breastfeeding: Safety, Benefits, and Current Research — how it works, what it costs, and how to find a provider who actually knows what they're doing.
The TMS Patient Buyer's Guide
Free 22-page guide — questions to ask, red flags, and how to choose the right provider.
Perinatal depression, which includes depression during pregnancy and the postpartum period, affects approximately 10-20% of mothers and represents one of the most common complications of childbirth. Left untreated, perinatal depression is associated with adverse outcomes for both mother and child, including poor prenatal care, preterm birth, developmental delays, and mother-infant attachment problems.
Standard antidepressant medications pose challenges during pregnancy due to potential fetal exposure and uncertain risk-benefit ratios. Electroconvulsive therapy (ECT), while effective, requires anesthesia and carries risks. Transcranial magnetic stimulation offers a non-pharmacological alternative that may be safer for pregnant women and their developing babies. However, the evidence base, while growing, remains limited.
What You’ll Learn
- Why TMS is an attractive option for perinatal depression with minimal systemic effects
- What the limited research shows about TMS safety and effectiveness in pregnancy
- Theoretical concerns about TMS during pregnancy and why they have not been substantiated
- Why TMS is compatible with breastfeeding unlike many psychiatric medications
- Practical considerations for scheduling and positioning during pregnancy
Understanding Perinatal Depression
Perinatal depression is distinct from depression occurring at other times of life. The hormonal fluctuations, metabolic changes, sleep disruption, and psychosocial stressors of pregnancy and new motherhood create a unique vulnerability.
During pregnancy, depression may manifest as:
- Persistent sadness or irritability
- Difficulty bonding with the developing baby
- Changes in appetite and sleep beyond typical pregnancy symptoms
- Anxiety about pregnancy, delivery, or parenthood
- Withdrawal from prenatal care
Postpartum depression symptoms are similar but may also include:
- Difficulty caring for or bonding with the baby
- Overwhelming fatigue
- Feelings of worthlessness or inadequacy as a mother
- Intrusive thoughts about harming the baby (requires urgent evaluation)
Why TMS Is Attractive During Pregnancy
The appeal of TMS for perinatal depression stems from several key features:
Minimal systemic effects — Unlike medications that circulate through the bloodstream and cross the placenta, TMS produces localized effects in the brain. The magnetic field does not reach the fetus directly.
Non-invasive — No surgery, anesthesia, or medication administration required.
Established safety profile — TMS has a well-characterized safety profile in the general adult population, though data in pregnancy specifically is limited.
Targeted mechanism — TMS can directly modulate the neural circuits involved in mood regulation, potentially bypassing systemic pathways.
Possibility of breastfeeding — Unlike many medications that are contraindicated during breastfeeding, TMS does not introduce any substances into breast milk.
What the Evidence Shows
TMS During Pregnancy
The evidence for TMS during pregnancy is limited but growing. Published evidence consists mainly of case reports, case series, open-label studies, and a small number of sham-controlled trials. Recent reviews of this literature (for example, this 2025 review of efficacy and safety in pregnancy) report that TMS appears to be well tolerated, with no significant risks to the pregnant woman or fetus identified, and with reductions in depression scores in many participants. One side effect noted is low blood pressure when lying back late in pregnancy, which sometimes requires repositioning.
While these results are encouraging, the sample sizes remain small, and larger controlled trials are needed to establish definitive safety and efficacy.
TMS and Fetal Safety
The theoretical concerns about TMS during pregnancy center on:
Heat generation — The coil can warm the scalp slightly. This is not expected to affect the fetus, which is far from the stimulation site.
Fetal magnetic field exposure — The TMS magnetic field dissipates rapidly with distance, and the fetus is far from the coil, so exposure is expected to be negligible.
Acoustic effects — The clicking sound of the TMS coil produces some acoustic exposure, but this is easily mitigated with earplugs.
Uterine contractions — No studies have linked TMS to uterine contractions, and the field is not expected to reach uterine tissue.
Risks of untreated depression — Untreated maternal depression is associated with adverse outcomes, which is part of why treatment is worth discussing even though TMS data in pregnancy are limited.
TMS While Breastfeeding
Unlike most psychiatric medications, TMS does not introduce any substances into breast milk. This makes it an attractive option for breastfeeding mothers who need treatment for depression but wish to continue nursing.
The practical considerations are minimal:
- No waiting period is needed between TMS and breastfeeding
- No effect on milk supply or composition has been reported, though lactation-specific studies are limited
- No medication reaches the infant through milk
- Can be scheduled around infant feeding routines
Treatment Considerations for Pregnant and Postpartum Women
Timing
TMS during pregnancy is typically initiated when:
- Depression is moderate to severe
- Psychotherapy has not been effective or is not appropriate
- Patient prefers non-pharmacological treatment
- Risk-benefit analysis favors TMS over medications
The first trimester is when fetal organ development occurs, and some clinicians may prefer to delay elective treatments. However, severe untreated depression also poses risks during this critical period. Decisions should be individualized.
Session Logistics
Pregnant women may find TMS sessions increasingly challenging as pregnancy progresses due to:
- Physical discomfort lying flat (support pillows can help)
- Frequent bathroom breaks
- Nausea or fatigue
Scheduling flexibility and accommodations for pregnancy-related needs are important.
Co-occurring Anxiety
Perinatal depression is frequently accompanied by anxiety. TMS protocols can address both depression and anxiety, as the DLPFC plays a role in both conditions. Some evidence suggests that anxiety symptoms may be more resistant to TMS than depression, requiring higher treatment doses or longer protocols.
Integration with Perinatal Care
Optimal care for perinatal depression should include:
- Close coordination between TMS providers and obstetricians
- Monitoring of pregnancy progress throughout treatment
- Attention to psychosocial support and home environment
- Planning for postpartum care and relapse prevention
- Support for infant feeding decisions (breastfeeding or formula)
The Bottom Line
TMS represents a promising option for perinatal depression that offers antidepressant efficacy without fetal medication exposure or risks during breastfeeding. The current evidence is limited, but it has not identified evidence of harm, and early results suggest benefit in some patients.
Pregnant and breastfeeding women with depression should discuss TMS with their obstetrician and psychiatrist to determine whether it is an appropriate option for their specific situation.
If you are pregnant or postpartum and experiencing depression, talk to your healthcare provider. Resources are available through Postpartum Support International (postpartum.net) and the Marce Society for reproductive mental health.
Frequently Asked Questions
Is TMS safe during pregnancy for the fetus?
Small studies and case series of TMS during pregnancy have not reported adverse fetal outcomes, but the evidence is limited and TMS is not specifically FDA-cleared for use in pregnancy. The magnetic field dissipates rapidly with distance and is not expected to reach the fetus. Discuss risks and benefits with your obstetrician and TMS provider.
Can I breastfeed while receiving TMS?
Yes. Unlike most psychiatric medications that require careful evaluation of breastfeeding compatibility, TMS introduces no substances into breast milk. There is no waiting period needed between TMS and breastfeeding, and no medication reaches the infant through milk.
What is the first trimester risk for TMS during pregnancy?
Some clinicians may prefer to delay elective TMS until after the first trimester when major organogenesis is complete. However, severe untreated depression also poses risks during this critical period including adverse effects on fetal development. Decisions about timing should be individualized based on depression severity and discussed with both your TMS provider and obstetrician.
Ready to Explore Your TMS Options?
Browse verified TMS providers, read real reviews, and find the right treatment for your situation.
Related reading
- TMS During Pregnancy: What the Safety Data Actually Shows
- TMS for Postpartum Depression: A Drug-Free Option for New Mothers
- TMS for Multiple Sclerosis: Addressing Fatigue, Depression, and Cognitive Impairment
- What TMS Actually Feels Like: A Session-by-Session Guide
- How to Prepare for Your First TMS Session
- Take the TMS candidacy quiz
